JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.

Employees

3,564

Sector

Drug Retailers

Calendar

08-26 - Q2 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
13/06/25	40.70 $	-2.05%	16,756,860
12/06/25	41.55 $	+2.21%	9,909,471
11/06/25	40.65 $	-1.33%	7,629,733
10/06/25	41.20 $	0.00%	9,552,490
09/06/25	41.20 $	+4.04%	15,982,090

Delayed Quote Hong Kong S.E., June 13, 2025 at 04:08 pm

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

BBB

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.23CNY

Average target price

40.86CNY

Spread / Average Target

+9.75%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Hong Kong S.E. Other stock markets 16:08:09 13/06/2025 HKT			5-day change	1st Jan Change
40.70 ^HKD	-2.05%		+2.78%	+44.84%

06-11	Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	MT
06-03	China, HK shares rise as banks and carmakers rally; trade talks eyed	RE

Capitalization	119B 130B 16.59B 14.35B 13.47B 12.21B 22.53B 1,429B 25.49B 157B 61.26B 654B 62.28B 60.94B 2,389B	P/E ratio 2025 *	32.2x	P/E ratio 2026 *	28.2x
Enterprise value	91.05B 99.53B 12.68B 10.97B 10.29B 9.33B 17.22B 1,092B 19.48B 120B 46.81B 500B 47.59B 46.57B 1,826B	EV / Sales 2025 *	1.37x	EV / Sales 2026 *	1.14x
Free-Float	32.24%	Yield 2025 *	-	Yield 2026 *	-

Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	06-11	MT
China, HK shares rise as banks and carmakers rally; trade talks eyed	06-03	RE
Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy	05-15	MT
JD Health International's Profit Jumps 4.6% in Q1	05-13	MT
JD Health International Posts Q1 Revenue Of RMB16.65 Billion	05-13	RE
Nomura Adjusts JD Health International's Price Target to HK$41.50 From HK$31, Keeps at Buy	03-10	MT
JD Health International Inc. Provides Revenue Guidance for the Year 2025	03-06	CI
JD Health International Inc., 2024 Earnings Call, Mar 06, 2025	03-06
JD Health International Logs 94% Higher Attributable Profit for 2024	03-06	MT
JD Health International Posts FY Revenue Of RMB 58,200 Million	03-06	RE
JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	03-06	CI
DeepSeek, Tariff Relief Drive Rally in Chinese Tech Stocks	02-14	DJ
Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	11-18	MT

Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	06-11	MT
Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy	05-15	MT
Nomura Adjusts JD Health International's Price Target to HK$41.50 From HK$31, Keeps at Buy	03-10	MT
Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	11-18	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	19/08/24	MT

JD Health International Inc. Stock

Equities

6618

KYG5074A1004

Drug Retailers

Valuation: JD Health International Inc.

Chart: JD Health International Inc.

Latest news: JD Health International Inc.

Last Transcript: JD Health International Inc.

Analysts' recommendations: JD Health International Inc.

Press Releases: JD Health International Inc.

News in other languages: JD Health International Inc.

Trading JD Health International Inc.

Quotes and Performance

Course Extremes

Managers and Directors: JD Health International Inc.

ETFs: JD Health International Inc.

Other Drug Retailers

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

JD com misses estimates quarterly sales	15/08/24	AQ
JD.com verslaat verwachtingen	16/08/23	AQ
JD.com lacks estimates	09/03/23	AQ
JD Health International : Next Day Disclosure Return	01/06/22	PU
JD Health International : Next Day Disclosure Return	26/04/22	PU

MÄRKTE ASIEN/Verluste auf breiter Front - Japan sehr schwach	03-07
MÄRKTE ASIEN/Hohe Verluste in Japan und Aufschläge in China	03-07
Borse Cina : Hong Kong chiude a -0,85% con settore tech sotto pressione	03/01/24
Las acciones de Hong Kong terminan a la baja en un clima de aversión al riesgo -- Market Talk	02/08/23
Point marchés-Peu de changements en vue en Europe en attendant la Fed (actualisé)	04/05/22

1 day	-2.05%
1 week	+2.78%
Current month	+1.37%
1 month	+7.11%
3 months	+21.86%
6 months	+36.81%
Current year	+44.84%

1 week	39.4	42.4
1 month	38.3	42.55
Current year	26.2	42.55
1 year	19.48	42.55
3 years	19.48	90.75
5 years	19.48	198.5
10 years	19.48	198.5

Manager	Title	Age	Since
En Lin Jin CEO	Chief Executive Officer	45	06/09/2021
Deng Hui DFI	Director of Finance/CFO	39	11/05/2023
Ming King Chiu SEC	Corporate Secretary	48	-

Director	Title	Age	Since
Qiang Dong Liu CHM	Chairman	53	14/09/2020
Qing Qing Yi BRD	Director/Board Member	53	21/08/2020
Xing Yao Chen BRD	Director/Board Member	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
JD HEALTH INTERNATIONAL INC.	-2.05%	+2.78%	+64.11%	-19.00%	16.59B
WALGREENS BOOTS ALLIANCE, INC.	+0.26%	+1.24%	-26.28%	-71.72%	9.85B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-3.16%	+2.22%	+27.42%	-1.71%	9.44B
MATSUKIYOCOCOKARA & CO.	-0.04%	-0.93%	+34.58%	+66.95%	7.8B
CLICKS GROUP LIMITED	-3.43%	-4.52%	+20.13%	+29.54%	4.83B
NAHDI MEDICAL COMPANY	+0.48%	+5.84%	-3.94%	-17.02%	4.39B
YIFENG PHARMACY CHAIN CO., LTD.	-1.57%	-4.87%	-19.78%	-11.88%	4.22B
WELCIA HOLDINGS CO., LTD.	+0.10%	-1.15%	+26.29%	+0.80%	3.65B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-0.42%	+2.02%	-28.34%	+90.50%	3.04B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-2.57%	-5.84%	-8.60%	-31.49%	2.58B
Average	-1.24%	+0.14%	+8.56%	+3.50%	6.64B
Weighted average by Cap.	-1.36%	+0.90%	+19.84%	-4.53%

	2025 *	2026 *
Net sales	66.55B 72.75B 9.27B 8.02B 7.52B 6.82B 12.59B 798B 14.24B 87.93B 34.21B 365B 34.79B 34.04B 1,334B	75.09B 82.09B 10.46B 9.05B 8.49B 7.69B 14.2B 900B 16.06B 99.22B 38.61B 412B 39.25B 38.41B 1,506B
Net income	3.6B 3.94B 501M 434M 407M 369M 681M 43.18B 770M 4.76B 1.85B 19.77B 1.88B 1.84B 72.21B	4.08B 4.46B 569M 492M 462M 418M 772M 48.96B 874M 5.4B 2.1B 22.42B 2.13B 2.09B 81.89B
Net Debt	-28.09B -30.71B -3.91B -3.38B -3.18B -2.88B -5.31B -337B -6.01B -37.12B -14.44B -154B -14.69B -14.37B -563B	-33.44B -36.55B -4.66B -4.03B -3.78B -3.43B -6.32B -401B -7.15B -44.18B -17.19B -184B -17.48B -17.1B -670B